Compositions for reducing the incidence of drug induced arrhythmia

Details for Australian Patent Application No. 2006271230 (hide)

Owner The Procter and Gamble Company

Inventors Sprafka, Joseph Michael II; GoulartBrum, Jose Mauro

Agent Pizzeys

Pub. Number AU-A-2006271230

PCT Pub. Number WO2007/010498

Priority 60/701,555 22.07.05 US

Filing date 20 July 2006

Wipo publication date 25 January 2007

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/616 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2007/010498 Priority application(s): WO2007/010498

25 February 2010 Assignment before Grant

  The Procter & Gamble Company The application has been assigned to Warner Chilcott Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006271237-Oral care products

2006271219-Aerosol cream mousse, method of treating hair and use